ad image

Transposon Therapeutics

1 / 1
Transposon Therapeutics
Novel Nucleoside

Transposon Therapeutics Acquired a Portfolio of Novel Nucleoside Analogs for Oncology To Enhance Development Pipeline

Transposon Therapeutics

PR-11-24-NI-119Nov 21, 2024
Transposon Therapeutics
Clinical Trials

Transposon to Present Results from Phase 2 Study for the Treatment of ALS/FTD at the 7th Annual ALS ONE Research Symposium

Transposon Therapeutics

PR-10-24-NI-79Nov 07, 2024
1 / 1